ResearcherIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'OrsolaNo recent work listed
Elisa Grassi
Matched on ORCID iD 0000-0002-0410-1277; OpenAlex author ID A5102725532. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2015: 1 paper · 2016: none · 2017: none · 2018: 3 papers · 2019: none · 2020: 2 papers
Papers 6
- Searching for novel multimodal treatments in oligometastatic pancreatic cancer. First author DOI 10.1186/s12885-020-06718-3↗
- Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1). Co-author DOI 10.21873/anticanres.13975↗
- Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case report. First author DOI 10.1259/bjrcr.20170086↗
- Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief. Co-author DOI 10.2147/jpr.s167994↗
- Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. Co-author DOI 10.3892/ijo.2018.4344↗
- Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array. Co-author DOI 10.3892/mmr.2015.4344↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Riccardo Casadei · 5 shared papers, 2015–2020 · strength 0.38
- Paper Searching for novel multimodal treatments in oligometastatic pancreatic cancer. DOI 10.1186/s12885-020-06718-3↗
- Paper Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1). DOI 10.21873/anticanres.13975↗
- Paper Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case report. DOI 10.1259/bjrcr.20170086↗
- Mariacristina Di Marco · 5 shared papers, 2015–2020 · strength 0.38
- Paper Searching for novel multimodal treatments in oligometastatic pancreatic cancer. DOI 10.1186/s12885-020-06718-3↗
- Paper Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1). DOI 10.21873/anticanres.13975↗
- Paper Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case report. DOI 10.1259/bjrcr.20170086↗
- Claudio Ricci · 4 shared papers, 2015–2020 · strength 0.29
- Paper Searching for novel multimodal treatments in oligometastatic pancreatic cancer. DOI 10.1186/s12885-020-06718-3↗
- Paper Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case report. DOI 10.1259/bjrcr.20170086↗
- Paper Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, pre… DOI 10.3892/ijo.2018.4344↗
- Carla Serra · 3 shared papers, 2015–2020 · strength 0.21
- Paper Searching for novel multimodal treatments in oligometastatic pancreatic cancer. DOI 10.1186/s12885-020-06718-3↗
- Paper Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, pre… DOI 10.3892/ijo.2018.4344↗
- Paper Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by s… DOI 10.3892/mmr.2015.4344↗
- Daria Maria Filippini · 2 shared papers, 2018–2020 · strength 0.17
- Alessio Giuseppe Morganti · 2 shared papers, 2018–2020 · strength 0.17
- Gabriella Macchia · 2 shared papers, 2018–2020 · strength 0.17
- Milly Buwenge · 2 shared papers, 2018–2020 · strength 0.17
- Francesco Cellini · 2 shared papers, 2018–2020 · strength 0.17
- Alessandra Arcelli · 2 shared papers, 2018–2020 · strength 0.17
- S. Cammelli · 2 shared papers, 2018–2020 · strength 0.17
- Giorgio Ercolani · 2 shared papers, 2015–2020 · strength 0.15
- Francesca Comito · 2 shared papers, 2018 · strength 0.15
- Giovanni Brandi · 1 shared paper, 2020 · strength 0.11
- Francesco Minni · 2 shared papers, 2015–2018 · strength 0.10
- Paper Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, pre… DOI 10.3892/ijo.2018.4344↗
- Paper Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by s… DOI 10.3892/mmr.2015.4344↗
- Guido Biasco · 2 shared papers, 2015–2018 · strength 0.10
- Paper Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, pre… DOI 10.3892/ijo.2018.4344↗
- Paper Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by s… DOI 10.3892/mmr.2015.4344↗
- Savino Cilla · 1 shared paper, 2020 · strength 0.09
- Renzo Mazzarotto · 1 shared paper, 2020 · strength 0.09
- Nicola Simoni · 1 shared paper, 2020 · strength 0.09
- Lorenzo Fuccio · 1 shared paper, 2018 · strength 0.08
- Marina Macchini · 1 shared paper, 2015 · strength 0.04
- Antonio Daniele Pinna · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.